RSV Vaccines
Learning Objectives:
Presentation: Click Here
Evaluation: Click Here
Post Test: Click Here
Learning Objectives:
- Identify patients at risk of developing a severe RSV-related respiratory tract infection
- Apply the results of the Arexvy (GSK) and Abrysvo (Pfizer) phase III studies to patients when making a recommendation regarding an RSV vaccine
- Compare/contrast the Arexvy and Abrysvo RSV vaccines
Presentation: Click Here
Evaluation: Click Here
Post Test: Click Here